PG Course 2
Sunday, July 12, 2020 | 10:00 am - 2:00 pm ET

Enhanced Recovery After Surgery: Overcoming Barriers to Implementation 

Course Chair: Mikio Nihira, MD

Dr. Mikio Nihira is a Professor of Obstetrics and Gynecology in the Division of Female Pelvic Medicine and Reconstructive Surgery at the University of California at Riverside. He completed his residency training in Obstetrics and Gynecology at the University of California at Los Angeles. In 2001, he completed a three-year fellowship in Urogynecology and Reconstructive Pelvic Surgery at the Greater Baltimore Medical Center, the University of Maryland and the Johns Hopkins Hospital.

Dr. Nihira is a Fellow of the American College of Obstetrics and Gynecology and the American College of Surgeons. He is a Diplomate of the American Board of Obstetrics and Gynecology. He is amongst the first individuals to be certified by the American Board of Obstetrics and Gynecology as a subspecialist in Female Pelvic Medicine and Reconstructive Surgery. He is a member of the Society of Gynecologic Surgeons, American Urogynecologic Society and National Association for Continence. He has authored numerous scientific journal articles plus several textbook chapters in gynecology and urogynecology. He is a nationally recognized expert in female pelvic floor disorders and has been quoted in such publications as the Chicago Sun Times, Dallas Morning News and Shape magazine.

He is passionate about improving patient care experiences through efforts such as Enhanced-Recovery after Surgery (ERAS) pathways. Critical to this effort are training physicians how to minimize opioid to manage pain and to identify and address substance abuse in patients.

His clinical expertise includes the treatment of urinary and fecal incontinence, pelvic organ prolapse and other pelvic floor disorders. His research expertise involves developing criterion-based educational training curricula for postgraduate surgical training, measuring the effectiveness of ERAS and the application of diagnostic ultrasound to develop and improve surgical technologies such as autologous muscle graft injection into the urethra for the treatment of stress urinary incontinence.